CAS 26560-38-3

calcium dihydride - N-[(4-{[(2-amino-5-methyl-4-oxo-1,4,5,6,7,8-hexahydropteridin-6-yl)methyl]amino}phenyl)carbonyl]glutamic acid (1:1)

Description:

Calcium dihydride - N-[(4-{[(2-amino-5-methyl-4-oxo-1,4,5,6,7,8-hexahydropteridin-6-yl)methyl]amino}phenyl)carbonyl]glutamic acid (1:1), with CAS number 26560-38-3, is a complex chemical compound that combines calcium dihydride, a hydride of calcium known for its use as a reducing agent and in hydrogen storage, with a specific amino acid derivative. The presence of the pteridinyl moiety suggests potential biological activity, as pteridines are often involved in various biochemical processes, including enzyme function and cofactor roles. The glutamic acid component indicates that this compound may have applications in biochemistry or pharmaceuticals, particularly in drug design or as a biochemical probe. The structure likely exhibits both ionic and covalent characteristics due to the presence of the calcium ion and the organic functional groups, which may influence its solubility, reactivity, and interaction with biological systems. Overall, this compound represents a unique intersection of inorganic and organic chemistry, with potential implications in medicinal chemistry and materials science.

Formula: C₂₀H₂₇CaN₇O₆

InChI: InChI=1/C20H25N7O6.Ca.2H/c1-27-12(9-23-16-15(27)18(31)26-20(21)25-16)8-22-11-4-2-10(3-5-11)17(30)24-13(19(32)33)6-7-14(28)29;;;/h2-5,12-13,22H,6-9H2,1H3,(H,24,30)(H,28,29)(H,32,33)(H4,21,23,25,26,31);;;/q;+2;2*-1

Synonyms:

• 5-Methyltetrahydrofolate calcium (racemate)
• 5-Methyltetrahydrofolate calcium
• L-Glutamic acid, N-4-(2-amino-1,4,5,6,7,8-hexahydro-5-methyl-4-oxo-6-pteridinyl)methylaminobenzoyl-, calcium salt (1:1)
• Calcium 5-methyltetrahydrofolate

Calcium D,L-5-Methyltetrahydrofolate

CAS: 26560-38-3

Other vitamins and their derivatives, nesoi

Formula: C₂₀H₂₃CaN₇O₆

Color and Shape: White Beige Powder

Molecular weight: 497.13357

Ref: 45-1379081

L-Glutamic acid, N-[4-[[(2-amino-3,4,5,6,7,8-hexahydro-5-methyl-4-oxo-6-pteridinyl)methyl]amino]benzoyl]-, calcium salt (1:1)

CAS: 26560-38-3

Formula: C₂₀H₂₃CaN₇O₆

Purity: 98%

Color and Shape: Solid

Molecular weight: 497.5179

Ref: IN-DA002TP3

Calcium N5-methyltetrahydrofolate

CAS: 26560-38-3

Calcium N5-methyltetrahydrofolate

Purity: ≥98%

Molecular weight: 497.51g/mol

Ref: 54-BUP02465

5-(Methyl-d3)-Tetrahydrofolic Acid Calcium Salt

CAS: 26560-38-3

Formula: C₂₀H₂₀D₃N₇O₆·Ca

Molecular weight: 460.47 40.08

Ref: 4Z-F-2442

5-Methyl-Tetrahydrofolic Acid Calcium Salt

CAS: 26560-38-3

Formula: C₂₀H₂₃N₇O₆·Ca

Molecular weight: 457.45 40.08

Ref: 4Z-F-2441

Calcium N5-methyltetrahydrofolate

CAS: 26560-38-3

Calcium N5-methyltetrahydrofolate (NSC-173328) is the calcium salt of levomefolic acid, which has been proposed for treatment of cardiovascular disease and

Formula: C₂₀H₂₃CaN₇O₆

Purity: 99.41%

Color and Shape: Solid

Molecular weight: 497.51

Ref: TM-T7598

5-Methyltetrahydrofolic Acid Calcium Salt Hydrate

Controlled Product

CAS: 134-35-0, 26560-38-3

Formula: C₂₀H₂₃CaN₇O₆•xH₂O

Color and Shape: White To Beige

Molecular weight: 497.52

Ref: TR-M330135

5-(Methyl-d3)tetrahydrofolic Acid Calcium Salt (Mixture of Diastereomers)

Controlled Product

CAS: 26560-38-3

Stability Hygroscopic
Applications 5-(Methyl-d3)tetrahydrofolic Acid Calcium Salt is a labelled metabolite of Folic Acid (F680300); inhibits photosensitization reactions and strand breaks in DNA; reduces total serum homocysteine level in orthotopic liver transplant recipients.
References Fassbender, K., et al.: Lancet, 353, 1586 (1999); Pruthi, J., et al.: Liver Transpl., 7, 811 (2001); Wu, L., et al.: Clin. Chim. Acta, 322, 21 (2002); Eisen, H., et al.: N. Engl. J. Med., 349, 847 (2003)

Formula: C₂₀D₃H₂₀N₇O₆·Ca

Color and Shape: Neat

Molecular weight: 500.54

Ref: TR-M330132

Calcium 5-methyltetrahydrofolate

CAS: 26560-38-3

Calcium 5-methyltetrahydrofolate is a prodrug that is converted to 5-methyltetrahydrofolate in the body. It is used for the treatment of hyperhomocysteinemia, which is a condition characterized by abnormally high levels of homocysteine in the blood. The conversion of calcium folate to tetrahydrofolate occurs inside cells and requires an optimal reaction time and chloride ion concentration. Calcium folate has been shown to be an effective treatment for hyperhomocysteinemia in patients with defects in MTHFR, which are enzymes involved in converting folic acid into 5-methyltetrahydrofolate. This drug also has been shown to normalize homocysteine levels in individuals with MTHFR polymorphisms, or genetic variations that affect the function of enzymes involved in metabolism.

Formula: C₂₀H₂₃CaN₇O₆

Purity: Min. 95 Area-%

Color and Shape: Powder

Molecular weight: 497.52 g/mol

Ref: 3D-FM29467